Skip to main content
OpenTrials

Clinical trial condition

Ovarian Diseases

Explore clinical trials studying Ovarian Diseases. Study availability and eligibility vary by location and protocol.

3,406 public trials 661 recruiting studies
Refine in advanced search Browse all conditions

Ovarian Diseases trial results

Completed

A Study of DSP-7888 Dosing Emulsion in Adult Patients With Advanced Malignancies

NCT02498665

Conditions
Acute Myeloid Leukemia, Adenocarcinoma, Adnexal Diseases, +67 more
Locations
  • USOR - Rocky Mountain Cancer Center Denver, Colorado, United States
  • Emory University Winship Cancer Institute Atlanta, Georgia, United States
  • Horizon Oncology Research Lafayette, Indiana, United States
  • USOR - TX Oncology Austin Austin, Texas, United States
View Trial Details
Completed

First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors

NCT02729298

Conditions
Adnexal Diseases, Advanced Solid Tumors, BRAF-Mutated Melanoma, +26 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • University of Colorado Denver Denver, Colorado, United States
  • US Oncology - Rocky Mountain Cancer Centers, LLP (RMCC) Denver, Colorado, United States
View all 16 locations
View Trial Details
Completed

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

NCT00716976

Conditions
Adnexal Diseases, Brain Diseases, Brain Neoplasms, +62 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Childrens Hospital Los Angeles Los Angeles, California, United States
  • Southern California Permanente Medical Group Los Angeles, California, United States
View all 76 locations
View Trial Details
Completed

A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer.

NCT03840200

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +24 more
Locations
  • California Cancer Associates for Research & Excellence, Inc. San Marcos, California, United States
  • Regional Cancer Care Associates LLC, Central Jersey Division East Brunswick, New Jersey, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • Mary Crowley Medical Research Center; Oncology Dallas, Texas, United States
View all 17 locations
View Trial Details

Related conditions